MedPath
NMPA Approval

Levosimendan Injection

国药准字H20244375

July 9, 2024

Drug Information

左西孟旦注射液

注射剂

5ml:12.5mg

化学药品

July 9, 2024

Company Information

Applicant Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

Manufacturing Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左西孟旦注射液 - NMPA 批准文号 | MedPath